Pleiotropic functions of tumor suppressor WWOX in normal and cancer cells

Journal of Biological Chemistry

Volumn 290, Issue 52, 2015, Pages 30728-30735

  Abu Remaileh, Muhannad ^a   Joy Dodson, Emma ^a   Schueler Furman, Ora ^a   Aqeilan, Rami I ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GENES; METABOLISM;

ASSOCIATED FUNCTIONS; BINDING PARTNERS; BIOLOGICAL FUNCTIONS; CELLULAR ACTIVITIES; METABOLIC REGULATIONS; PLEIOTROPIC FUNCTIONS; TUMOR SUPPRESSOR GENES; TUMOR SUPPRESSORS;

TUMORS;

ATM PROTEIN; CHECKPOINT KINASE 2; COPPER ZINC SUPEROXIDE DISMUTASE; GLUCOSE TRANSPORTER 1; HISTONE H2AX; ISOCITRATE DEHYDROGENASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; WW DOMAIN CONTAINING OXIDOREDUCTASE; OXIDOREDUCTASE;

AMINO ACID SEQUENCE; ATAXIA; AUDIOGENIC SEIZURE; BRAIN DEVELOPMENT; BRAIN DISEASE; CANCER CELL; CANCER INCIDENCE; CARBOXY TERMINAL SEQUENCE; CENTRAL NERVOUS SYSTEM FUNCTION; DEGENERATIVE DISEASE; DNA DAMAGE; DROSOPHILA MELANOGASTER; EPILEPSY; EXON; FRAMESHIFT MUTATION; GENE DELETION; GENE LOCUS; GENETIC CONSERVATION; GLYCOLYSIS; HETEROZYGOSITY; HUMAN; METABOLIC REGULATION; NONHUMAN; PHENOTYPE; PHYLOGENY; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN STRUCTURE; REVIEW; TUMOR SUPPRESSOR GENE; WWOX GENE; ANIMAL; CENTRAL NERVOUS SYSTEM; CHEMISTRY; ENZYMOLOGY; GENETICS; METABOLISM; NEOPLASM; PROTEIN TERTIARY STRUCTURE;

ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; NEOPLASMS; OXIDOREDUCTASES; PROTEIN STRUCTURE, TERTIARY; TUMOR SUPPRESSOR PROTEINS;

EID: 84951804916     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.R115.676346     Document Type: Review

References (78)

1. Bednarek, A. K., Laflin, K. J., Daniel, R. L., Liao, Q., Hawkins, K. A., and Aldaz, C. M. (2000) WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res. 60, 2140-2145
2. Ried, K., Finnis, M., Hobson, L., Mangelsdorf, M., Dayan, S., Nancarrow, J. K., Woollatt, E., Kremmidiotis, G., Gardner, A., Venter, D., Baker, E., and Richards, R. I. (2000) Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum. Mol. Genet. 9, 1651-1663
3. Gao, G., and Smith, D. I. (2014) Very large common fragile site genes and their potential role in cancer development. Cell. Mol. Life Sci. 71, 4601-4615
4. Durkin, S. G., and Glover, T. W. (2007) Chromosome fragile sites. Annu. Rev. Genet. 41, 169-192
5. Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., Mc Henry, K. T., Pinchback, R. M., Ligon, A. H., Cho, Y. J., Haery, L., Greulich, H., Reich, M., Winckler, W., Lawrence, M. S., Weir, B. A., Tanaka, K. E., Chiang, D. Y., Bass, A. J., Loo, A., Hoffman, C., Prensner, J., Liefeld, T., Gao, Q., Yecies, D., Signoretti, S., Maher, E., Kaye, F. J., Sasaki, H., Tepper, J. E., Fletcher, J. A., Tabernero, J., Baselga, J., Tsao, M. S., Demichelis, F., Rubin, M. A., Janne, P. A., Daly, M. J., Nucera, C., Levine, R. L., Ebert, B. L., Gabriel, S., Rustgi, A. K., Antonescu, C. R., Ladanyi, M., Letai, A., Garraway, L. A., Loda, M., Beer, D. G., True, L. D., Okamoto, A., Pomeroy, S. L., Singer, S., Golub, T. R., Lander, E. S., Getz, G., Sellers, W. R., and Meyerson, M. (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463, 899-905
6. Aldaz, C. M., Ferguson, B. W., and Abba, M. C. (2014) WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies. Biochim. Biophys. Acta 1846, 188-200
7. Aqeilan, R. I., and Croce, C. M. (2007) WWOX in biological control and tumorigenesis. J. Cell. Physiol. 212, 307-310
8. Chang, N. S., Hsu, L. J., Lin, Y. S., Lai, F. J., and Sheu, H. M. (2007) WW domain-containing oxidoreductase: a candidate tumor suppressor. Trends Mol. Med. 13, 12-22
9. Del Mare, S., Salah, Z., and Aqeilan, R. I. (2009) WWOX: its genomics, partners, and functions. J. Cell. Biochem. 108, 737-745
10. Gardenswartz, A., and Aqeilan, R. I. (2014)WWdomain-containing oxidoreductase's role in myriad cancers: Clinical significance and future implications. Exp. Biol. Med. (Maywood) 239, 253-263
11. Richards, R. I., Choo, A., Lee, C. S., Dayan, S., and O'Keefe, L. (2015) WWOX, the chromosomal fragile site FRA16D spanning gene: Its role in metabolism and contribution to cancer. Exp. Biol. Med. (Maywood) 240, 338-344
12. Krummel, K. A., Denison, S. R., Calhoun, E., Phillips, L. A., and Smith, D. I. (2002) The common fragile site FRA16D and its associated gene WWOX are highly conserved in the mouse at Fra8E1. Genes Chromosomes Cancer 34, 154-167
13. Abdeen, S. K., Salah, Z., Maly, B., Smith, Y., Tufail, R., Abu-Odeh, M., Zanesi, N., Croce, C. M., Nawaz, Z., and Aqeilan, R. I. (2011) Wwox inactivation enhances mammary tumorigenesis. Oncogene 30, 3900-3906
14. Aqeilan, R. I., Hagan, J. P., Aqeilan, H. A., Pichiorri, F., Fong, L. Y., and Croce, C. M. (2007) Inactivation of the Wwox gene accelerates forestomach tumor progression in vivo. Cancer Res. 67, 5606-5610
15. Aqeilan, R. I., Trapasso, F., Hussain, S., Costinean, S., Marshall, D., Pekarsky, Y., Hagan, J. P., Zanesi, N., Kaou, M., Stein, G. S., Lian, J. B., and Croce, C. M. (2007) Targeted deletion of Wwox reveals a tumor suppressor function. Proc. Natl. Acad. Sci. U.S.A. 104, 3949-3954
16. Ludes-Meyers, J. H., Kil, H., Nuñez, M. I., Conti, C. J., Parker-Thornburg, J., Bedford, M. T., and Aldaz, C. M. (2007) Wwox hypomorphic mice display a higher incidence of B-cell lymphomas and develop testicular atrophy. Genes Chromosomes Cancer 46, 1129-1136
17. Aqeilan, R. I., Hassan, M. Q., de Bruin, A., Hagan, J. P., Volinia, S., Palumbo, T., Hussain, S., Lee, S. H., Gaur, T., Stein, G. S., Lian, J. B., and Croce, C. M. (2008) The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism. J. Biol. Chem. 283, 21629-21639
18. Aqeilan, R. I., Hagan, J. P., de Bruin, A., Rawahneh, M., Salah, Z., Gaudio, E., Siddiqui, H., Volinia, S., Alder, H., Lian, J. B., Stein, G. S., and Croce, C. M. (2009) Targeted ablation of the WW domain-containing oxidoreductase tumor suppressor leads to impaired steroidogenesis. Endocrinology 150, 1530-1535
19. Abu-Remaileh, M., and Aqeilan, R. I. (2015) The tumor suppressorWW domain-containing oxidoreductase modulates cell metabolism. Exp. Biol. Med. (Maywood) 240, 345-350
20. Mallaret, M., Synofzik, M., Lee, J., Sagum, C. A., Mahajnah, M., Sharkia, R., Drouot, N., Renaud, M., Klein, F. A., Anheim, M., Tranchant, C., Mignot, C., Mandel, J. L., Bedford, M., Bauer, P., Salih, M. A., Schüle, R., Schöls, L., Aldaz, C. M., and Koenig, M. (2014) The tumour suppressor geneWWOX is mutated in autosomal recessive cerebellar ataxia with epilepsy and mental retardation. Brain 137, 411-419
21. Ludes-Meyers, J. H., Kil, H., Parker-Thornburg, J., Kusewitt, D. F., Bedford, M. T., and Aldaz, C. M. (2009) Generation and characterization of mice carrying a conditional allele of the Wwox tumor suppressor gene. PLoS ONE 4, e7775
22. Abdeen, S. K., Del Mare, S., Hussain, S., Abu-Remaileh, M., Salah, Z., Hagan, J., Rawahneh, M., Pu, X. A., Russell, S., Stein, J. L., Stein, G. S., Lian, J. B., and Aqeilan, R. I. (2013) Conditional inactivation of the mouse Wwox tumor suppressor gene recapitulates the null phenotype. J. Cell. Physiol. 228, 1377-1382
23. Suzuki, H., Katayama, K., Takenaka, M., Amakasu, K., Saito, K., and Suzuki, K. (2009) A spontaneous mutation of the Wwox gene and audiogenic seizures in rats with lethal dwarfism and epilepsy. Genes Brain Behav. 8, 650-660
24. Pandey, U. B., and Nichols, C. D. (2011) Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery. Pharmacol Rev. 63, 411-436
25. O'Keefe, L. V., Lee, C. S., Choo, A., and Richards, R. I. (2015) Tumor suppressorWWOXcontributes to the elimination of tumorigenic cells in Drosophila melanogaster. PLoS ONE 10, e0136356
26. Tsuruwaka, Y., Konishi, M., and Shimada, E. (2015) Loss of wwox expression in zebrafish embryos causes edema and alters Ca2+ dynamics. PeerJ. 3, e727
27. Bandmann, O., and Burton, E. A. (2010) Genetic zebrafish models of neurodegenerative diseases. Neurobiol Dis 40, 58-65
28. Chen, H. I., and Sudol, M. (1995) The WW domain of Yes-Associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. Proc. Natl. Acad. Sci. U.S.A. 92, 7819-7823
29. Sudol, M., Bork, P., Einbond, A., Kastury, K., Druck, T., Negrini, M., Huebner, K., and Lehman, D. (1995) Characterization of the mammalian YAP (Yes-Associated protein) gene and its role in defining a novel protein module, theWWdomain. J. Biol. Chem. 270, 14733-14741
30. Aqeilan, R. I., Pekarsky, Y., Herrero, J. J., Palamarchuk, A., Letofsky, J., Druck, T., Trapasso, F., Han, S. Y., Melino, G., Huebner, K., and Croce, C. M. (2004) Functional association between Wwox tumor suppressor protein and p73, a p53 homolog. Proc. Natl. Acad. Sci. U.S.A. 101, 4401-4406
31. Hu, H., Columbus, J., Zhang, Y., Wu, D., Lian, L., Yang, S., Goodwin, J., Luczak, C., Carter, M., Chen, L., James, M., Davis, R., Sudol, M., Rodwell, J., and Herrero, J. J. (2004) A map of WW domain family interactions. Proteomics 4, 643-655
32. Aqeilan, R. I., Donati, V., Palamarchuk, A., Trapasso, F., Kaou, M., Pekarsky, Y., Sudol, M., and Croce, C. M. (2005)WWdomain-containing proteins, WWOXand YAP, compete for interaction with ErbB-4 and modulate its transcriptional function. Cancer Res. 65, 6764-6772
33. Aqeilan, R. I., Palamarchuk, A., Weigel, R. J., Herrero, J. J., Pekarsky, Y., and Croce, C. M. (2004) Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2γ transcription factor. Cancer Res. 64, 8256-8261
34. Salah, Z., Aqeilan, R., and Huebner, K. (2010) WWOX gene and gene product: tumor suppression through specific protein interactions. Future Oncol 6, 249-259
35. Aqeilan, R. I., Donati, V., Gaudio, E., Nicoloso, M. S., Sundvall, M., Korhonen, A., Lundin, J., Isola, J., Sudol, M., Joensuu, H., Croce, C. M., and Elenius, K. (2007) Association of Wwox with ErbB4 in breast cancer. Cancer Res. 67, 9330-9336
36. Guler, G., Iliopoulos, D., Guler, N., Himmetoglu, C., Hayran, M., and Huebner, K. (2007) Wwox and Ap2γ expression levels predict tamoxifen response. Clin. Cancer Res. 13, 6115-6121
37. Ludes-Meyers, J. H., Kil, H., Bednarek, A. K., Drake, J., Bedford, M. T., and Aldaz, C. M. (2004) WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteins. Oncogene 23, 5049-5055
38. Ferguson, B. W., Gao, X., Zelazowski, M. J., Lee, J., Jeter, C. R., Abba, M. C., and Aldaz, C. M. (2013) The cancer geneWWOXbehaves as an inhibitor of SMAD3 transcriptional activity via direct binding.BMCCancer 13, 593
39. Salah, Z., Alian, A., and Aqeilan, R. I. (2012) WW domain-containing proteins: retrospectives and the future. Front. Biosci. 17, 331-348
40. Dodson, E. J., Fishbain-Yoskovitz, V., Rotem-Bamberger, S., and Schueler-Furman, O. (2015) Versatile communication strategies among tandem WWdomain repeats. Exp. Biol. Med. (Maywood) 240, 351-360
41. Abu-Odeh, M., Bar-Mag, T., Huang, H., Kim, T., Salah, Z., Abdeen, S. K., Sudol, M., Reichmann, D., Sidhu, S., Kim, P. M., and Aqeilan, R. I. (2014) Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks. J. Biol. Chem. 289, 8865-8880
42. McDonald, C. B., Buffa, L., Bar-Mag, T., Salah, Z., Bhat, V., Mikles, D. C., Deegan, B. J., Seldeen, K. L., Malhotra, A., Sudol, M., Aqeilan, R. I., Nawaz, Z., and Farooq, A. (2012) Biophysical basis of the binding of WWOX tumor suppressor to WBP1 and WBP2 adaptors. J. Mol. Biol. 422, 58-74
43. Farooq, A. (2015) Structural insights into the functional versatility ofWW domain-containing oxidoreductase tumor suppressor. Exp. Biol. Med. (Maywood) 240, 361-374
44. Schuchardt, B. J., Bhat, V., Mikles, D. C., McDonald, C. B., Sudol, M., and Farooq, A. (2013) Molecular origin of the binding of WWOX tumor suppressor to ErbB4 receptor tyrosine kinase. Biochemistry 52, 9223-9236
45. O'Keefe, L. V., Colella, A., Dayan, S., Chen, Q., Choo, A., Jacob, R., Price, G., Venter, D., and Richards, R. I. (2011) Drosophila orthologue of WWOX, the chromosomal fragile site FRA16D tumour suppressor gene, functions in aerobic metabolism and regulates reactive oxygen species. Hum. Mol. Genet. 20, 497-509
46. Dayan, S., O'Keefe, L. V., Choo, A., and Richards, R. I. (2013) Common chromosomal fragile site FRA16D tumor suppressorWWOXgene expression and metabolic reprograming in cells. Genes Chromosomes Cancer 52, 823-831
47. Abu-Remaileh, M., and Aqeilan, R. I. (2014) Tumor suppressor WWOX regulates glucose metabolism via HIF1α modulation. Cell Death Differ. 21, 1805-1814
48. Abu-Remaileh, M., Seewaldt, V. L., and Aqeilan, R. I. (2014) WWOX loss activates aerobic glycolysis. Mol. Cell. Oncol. 2, e965640
49. Choo, A., O'Keefe, L. V., Lee, C. S., Gregory, S. L., Shaukat, Z., Colella, A., Lee, K., Denton, D., and Richards, R. I. (2015) Tumor suppressorWWOX moderates the mitochondrial respiratory complex. Genes Chromosomes Cancer 54, 745-761
50. Aqeilan, R. I., Abu-Remaileh, M., and Abu-Odeh, M. (2014) The common fragile site FRA16D gene product WWOX: roles in tumor suppression and genomic stability. Cell. Mol. Life Sci. 71, 4589-4599
51. Abu-Odeh, M., Salah, Z., Herbel, C., Hofmann, T. G., and Aqeilan, R. I. (2014) WWOX, the common fragile site FRA16D gene product, regulates ATM activation and the DNA damage response. Proc. Natl. Acad. Sci. U.S.A. 111, E4716-E4725
52. Hazan, I., Abu Odeh, M., Hofmann, T. G., and Aqeilan, R. I. (2015) WWOX guards genome stability by activating ATM. Mol. Cell. Oncol. 2, e1008288
53. Letessier, A., Millot, G. A., Koundrioukoff, S., Lachagés, A. M., Vogt, N., Hansen, R. S., Malfoy, B., Brison, O., and Debatisse, M. (2011) Cell-typespecific replication initiation programs set fragility of the FRA3B fragile site. Nature 470, 120-123
54. Le Tallec, B., Millot, G. A., Blin, M. E., Brison, O., Dutrillaux, B., and Debatisse, M. (2013) Common fragile site profiling in epithelial and erythroid cells reveals that most recurrent cancer deletions lie in fragile sites hosting large genes. Cell Rep. 4, 420-428
55. Chang, N. S., Doherty, J., and Ensign, A. (2003) JNK1 physically interacts with WW domain-containing oxidoreductase (WOX1) and inhibits WOX1-mediated apoptosis. J. Biol. Chem. 278, 9195-9202
56. Chang, N. S., Doherty, J., Ensign, A., Schultz, L., Hsu, L. J., and Hong, Q. (2005) WOX1 is essential for tumor necrosis factor-, UV light-, staurosporine-, and p53-mediated cell death, and its tyrosine 33-phosphorylated form binds and stabilizes serine 46-phosphorylated p53. J. Biol. Chem. 280, 43100-43108
57. Bouteille, N., Driouch, K., Hage, P. E., Sin, S., Formstecher, E., Camonis, J., Lidereau, R., and Lallemand, F. (2009) Inhibition of the Wnt/β-catenin pathway by theWWOXtumor suppressor protein. Oncogene 28, 2569-2580
58. Baugh, L., Phan, I., Begley, D. W., Clifton, M. C., Armour, B., Dranow, D. M., Taylor, B. M., Muruthi, M. M., Abendroth, J., Fairman, J. W., Fox, D., 3rd, Dieterich, S. H., Staker, B. L., Gardberg, A. S., Choi, R., Hewitt, S. N., Napuli, A. J., Myers, J., Barrett, L. K., Zhang, Y., Ferrell, M., Mundt, E., Thompkins, K., Tran, N., Lyons-Abbott, S., Abramov, A., Sekar, A., Serbzhinskiy, D., Lorimer, D., Buchko, G. W., Stacy, R., Stewart, L. J., Edwards, T. E., Van Voorhis, W. C., and Myler, P. J. (2015) Increasing the structural coverage of tuberculosis drug targets. Tuberculosis (Edinb.) 95, 142-148
59. Nunez, M. I., Ludes-Meyers, J., and Aldaz, C. M. (2006) WWOX protein expression in normal human tissues. J. Mol. Histol 37, 115-125
60. Chen, S. T., Chuang, J. I., Wang, J. P., Tsai, M. S., Li, H., and Chang, N. S. (2004) Expression of WW domain-containing oxidoreductase WOX1 in the developing murine nervous system. Neuroscience 124, 831-839
61. Abdel-Salam, G., Thoenes, M., Afifi, H. H., Körber, F., Swan, D., and Bolz, H. J. (2014) The supposed tumor suppressor geneWWOXis mutated in an early lethal microcephaly syndrome with epilepsy, growth retardation and retinal degeneration. Orphanet J. Rare Dis. 9, 12
62. Ben-Salem, S., Al-Shamsi, A. M., John, A., Ali, B. R., and Al-Gazali, L. (2015) A novel whole exon deletion inWWOXgene causes early epilepsy, intellectual disability and optic atrophy. J. Mol. Neurosci. 56, 17-23
63. Mignot, C., Lambert, L., Pasquier, L., Bienvenu, T., Delahaye-Duriez, A., Keren, B., Lefranc, J., Saunier, A., Allou, L., Roth, V., Valduga, M., Moustaïne, A., Auvin, S., Barrey, C., Chantot-Bastaraud, S., Lebrun, N., Moutard, M. L., Nougues, M. C., Vermersch, A. I., Héron, B., Pipiras, E., Héron, D., Olivier-Faivre, L., Guéant, J. L., Jonveaux, P., and Philippe, C. (2015)WWOX-related encephalopathies: delineation of the phenotypical spectrum and emerging genotype-phenotype correlation. J. Med. Genet. 52, 61-70
64. Valduga, M., Philippe, C., Lambert, L., Bach-Segura, P., Schmitt, E., Masutti, J. P., François, B., Pinaud, P., Vibert, M., and Jonveaux, P. (2015) WWOX and severe autosomal recessive epileptic encephalopathy: first case in the prenatal period. J. Hum. Genet. 60, 267-271
65. Tabarki, B., AlHashem, A., AlShahwan, S., Alkuraya, F. S., Gedela, S., and Zuccoli, G. (2015) Severe CNS involvement in WWOX mutations: description of five new cases. Am. J. Med. Genet A, 10.1002/ajmg.a.37363
66. Tabarki, B., Al Mutairi, F., and Al Hashem, A. (2015) The fragile site WWOX gene and the developing brain. Exp. Biol. Med. (Maywood) 240, 400-402
67. Chang, H. T., Liu, C. C., Chen, S. T., Yap, Y. V., Chang, N. S., and Sze, C. I. (2014) WW domain-containing oxidoreductase in neuronal injury and neurological diseases. Oncotarget 5, 11792-11799
68. Sze, C. I., Su, M., Pugazhenthi, S., Jambal, P., Hsu, L. J., Heath, J., Schultz, L., and Chang, N. S. (2004) Down-regulation ofWWdomain-containing oxidoreductase induces Tau phosphorylation in vitro: a potential role in Alzheimer's disease. J. Biol. Chem. 279, 30498-30506
69. Wang, H. Y., Juo, L. I., Lin, Y. T., Hsiao, M., Lin, J. T., Tsai, C. H., Tzeng, Y. H., Chuang, Y. C., Chang, N. S., Yang, C. N., and Lu, P. J. (2012) WW domain-containing oxidoreductase promotes neuronal differentiation via negative regulation of glycogen synthase kinase 3β. Cell Death Differ. 19, 1049-1059
70. Yang, L., Liu, B., Huang, B., Deng, J., Li, H., Yu, B., Qiu, F., Cheng, M., Wang, H., Yang, R., Yang, X., Zhou, Y., and Lu, J. (2013) A functional copy number variation in theWWOXgene is associated with lung cancer risk in Chinese. Hum. Mol. Genet. 22, 1886-1894
71. Yu, K., Fan, J., Ding, X., Li, C., Wang, J., Xiang, Y., and Wang, Q. S. (2014) Association study of a functional copy number variation in theWWOXgene with risk of gliomas among Chinese people. Int. J. Cancer 135, 1687-1691
72. Yang, L., Qiu, F., Fang, W., Zhang, L., Xie, C., Lu, X., Huang, D., Guo, Y., Pan, M., Zhang, H., Zhou, Y., and Lu, J. (2015) The Functional Copy Number Variation-67048 in WWOX Contributes to Increased Risk of COPD in Southern and Eastern Chinese. COPD 12, 494-501
73. Macias, M. J., Hyvönen, M., Baraldi, E., Schultz, J., Sudol, M., Saraste, M., and Oschkinat, H. (1996) Structure of the WW domain of a kinase-Associated protein complexed with a proline-rich peptide. Nature 382, 646-649
74. Mahajan, N. P., Whang, Y. E., Mohler, J. L., and Earp, H. S. (2005) Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox. Cancer Res. 65, 10514-10523
75. Gribaa, M., Salih, M., Anheim, M., Lagier-Tourenne, C., H'mida, D., Drouot, N., Mohamed, A., Elmalik, S., Kabiraj, M., Al-Rayess, M., Almubarak, M., Bétard, C., Goebel, H., and Koenig, M. (2007) A new form of childhood onset, autosomal recessive spinocerebellar ataxia and epilepsy is localized at 16q21-q23. Brain 130, 1921-1928
76. Qi, S., O'Hayre, M., Gutkind, J. S., and Hurley, J. H. (2014) Structural and biochemical basis for ubiquitin ligase recruitment by arrestin-related domain-containing protein-3 (ARRDC3). J. Biol. Chem. 289, 4743-4752
77. Das, R., and Baker, D. (2008) Macromolecular modeling with rosetta. Annu. Rev. Biochem. 77, 363-382
78. Song, Y., DiMaio, F., Wang, R. Y., Kim, D., Miles, C., Brunette, T., Thompson, J., and Baker, D. (2013) High-resolution comparative modeling with RosettaCM. Structure 21, 1735-1742